Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02407405 |
|---|---|
| Brief Title: | MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas |
| First Submitted : | April 2, 2015 |
| First Submitted that Met QC Criteria : | April 2, 2015 |
| First Posted : | April 3, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | February 16, 2024 |
| Last Update Posted : | February 20, 2024 |